Literature DB >> 1726704

Analysis of the survival of mature human eosinophils: interleukin-5 prevents apoptosis in mature human eosinophils.

Y Yamaguchi1, T Suda, S Ohta, K Tominaga, Y Miura, T Kasahara.   

Abstract

We and other groups have previously shown that interleukin-5 (IL-5) maintained the viability of mature eosinophils in an in vitro liquid culture system. Mature eosinophils did not proliferate but their survival was maintained in the presence of IL-5. Using this culture system, we investigated the mechanism of IL-5-mediated survival. In the absence of human IL-5 (hIL-5) mature eosinophils succumbed after 4 days, while in the presence of hIL-5 they survived up to 10 days. When DNA extracts of cultured eosinophils were analyzed on an agar gel electrophoresis, marked DNA fragmentation was observed in the absence of hIL-5, while no significant DNA fragmentation was observed in the culture with hIL-5 for 48 hours. The DNA fragmentation appeared as early as 6 to 12 hours after hIL-5 deprivation. Concomitantly, IL-5 stimulated total RNA and protein synthesis, but did not induce DNA synthesis in mature eosinophils. Because cycloheximide or actinomycin D impeded the protection of apoptosis by hIL-5, some new RNA and protein synthesis appeared to be required in this phenomena. These findings indicate that IL-5 maintains survival of mature eosinophils with induction of new RNA and protein synthesis, thus leading to the inhibition of apoptosis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1726704

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  45 in total

1.  Mitochondria in eosinophils: functional role in apoptosis but not respiration.

Authors:  K K Peachman; D S Lyles; D A Bass
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

2.  Dimeric RFX proteins contribute to the activity and lineage specificity of the interleukin-5 receptor alpha promoter through activation and repression domains.

Authors:  A Iwama; J Pan; P Zhang; W Reith; B Mach; D G Tenen; Z Sun
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

3.  Rapid and efficient clearance of airway tissue granulocytes through transepithelial migration.

Authors:  J S Erjefält; L Uller; M Malm-Erjefält; C G Persson
Journal:  Thorax       Date:  2004-02       Impact factor: 9.139

4.  CCR2 deficiency leads to increased eosinophils, alternative macrophage activation, and type 2 cytokine expression in adipose tissue.

Authors:  W Reid Bolus; Dario A Gutierrez; Arion J Kennedy; Emily K Anderson-Baucum; Alyssa H Hasty
Journal:  J Leukoc Biol       Date:  2015-05-01       Impact factor: 4.962

5.  A potent dimeric peptide antagonist of interleukin-5 that binds two interleukin-5 receptor alpha chains.

Authors:  B P England; P Balasubramanian; I Uings; S Bethell; M J Chen; P J Schatz; Q Yin; Y F Chen; E A Whitehorn; A Tsavaler; C L Martens; R W Barrett; M McKinnon
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

6.  Excretory-secretory product of newly excysted metacercariae of Paragonimus westermani directly induces eosinophil apoptosis.

Authors:  M H Shin
Journal:  Korean J Parasitol       Date:  2000-03       Impact factor: 1.341

7.  New diagnostic tool for differentiation of idiopathic hypereosinophilic syndrome (HES) and secondary eosinophilic states.

Authors:  T Berki; M Dávid; B Bóné; H Losonczy; J Vass; P Németh
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

8.  The differential effect of dexamethasone on granulocyte apoptosis involves stabilization of Mcl-1L in neutrophils but not in eosinophils.

Authors:  Kelly L Sivertson; Michael C Seeds; David L Long; Kristina K Peachman; David A Bass
Journal:  Cell Immunol       Date:  2007-06-14       Impact factor: 4.868

9.  Immunomodulatory effects of ultra-low-dose interleukin-2 in cancer patients: a phase-IB study.

Authors:  A Lindemann; P Brossart; K Höffken; M Flasshove; D Voliotis; V Diehl; G Hecker; H Wagner; R Mertelsmann
Journal:  Cancer Immunol Immunother       Date:  1993-10       Impact factor: 6.968

Review 10.  Targeting eosinophils in allergy, inflammation and beyond.

Authors:  Patricia C Fulkerson; Marc E Rothenberg
Journal:  Nat Rev Drug Discov       Date:  2013-01-21       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.